ArticleUrologia internationalis2023

Prospective Evaluation of Health-Related Quality of Life in Patients with Metastatic Urothelial Carcinoma Undergoing Immunotherapy with Pembrolizumab: Symptom Burden Can Predict Survival.

Laila Schneidewind et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.